Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVIATOR: raltegravir-atorvastatin pharmacokinetic interaction study
NL-OMON38561Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of raltegravir and atorvastatin in human immunodeficiency virus infection (HIV) and dyslipidemia, sponsored by Radboud University Medical Center. Primary endpoints: Raltegravir pharmacokinetic interaction and Atorvastatin pharmacokinetic interaction. Started Apr 2013; status: active, not recruiting.
02
Drugs
raltegraviratorvastatin
03
Conditions
human immunodeficiency virus infection (HIV)dyslipidemia
Beyond the preview
Go deeper on NL-OMON38561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38561.